Gene expression analysis of decitabine treated AML: high impact of tumor suppressor gene expression changes

Tools

Item Type:	Letter
Title:	Gene expression analysis of decitabine treated AML: high impact of tumor suppressor gene expression changes
Creators Name:	Bohl, S.R., Dolnik, A., Jensen, T., Lang, K.M., Hackanson, B., Gaidzik, V.I., Paschka, P., Knudsen, S., Döhner, K., Döhner, H., Claus, R., Lübbert, M. and Bullinger, L.
Keywords:	Acute Myeloid Leukemia, Antineoplastic Antimetabolites, Azacitidine, Decitabine, Gene Expression Profiling, Kaplan-Meier Estimate, Leukemic Gene Expression Regulation, Transcriptome, Treatment Outcome, Tumor Biomarkers, Tumor Suppressor Genes
Source:	Leukemia & Lymphoma
ISSN:	1029-2403
Publisher:	Taylor & Francis
Volume:	58
Number:	9
Page Range:	2264-2267
Date:	2 September 2017
Official Publication:	https://doi.org/10.1080/10428194.2017.1287360
PubMed:	View item in PubMed

Repository Staff Only: item control page